Streptococcus suis serotype 2 mutants deficient in capsular expression

Microbiology

Volumn 144, Issue 2, 1998, Pages 325-332

  Charland, Nathalie ^a   Harel, Josée ^a   Kobisch, Marylène ^b   Lacasse, Serge ^a   Gottschalk, Marcelo ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Healthy Pigs Production and Experimentation Section   (France)

Author keywords

Capsule; Mutant; Streptococcus suis; Tn916; Virulence

Indexed keywords

POLYSACCHARIDE; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL MEMBRANE; BACTERIUM CONJUGATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HYDROPHOBICITY; MACROPHAGE; MONOCYTE; MOUSE; MUTAGENESIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS; SWINE; TRANSMISSION ELECTRON MICROSCOPY; TRANSPOSON; ZOONOSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; STREPTOCOCCUS SUIS; SUIDAE; SUS SCROFA;

EID: 0031936119     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/00221287-144-2-325     Document Type: Article

References (46)

1. Absolom, R. (1988). The role of bacterial hydrophobicity in infection: bacterial adhesion and phagocytic ingestion. Can J Microbiol 34, 287-298.
2. Arends, J. P. & Zanen, H. (1988). Meningitis caused by Streptococcus suis in humans. Rev Infect Dis 10, 131-137.
3. Beaudoin, M., Higgins, R., Harel, J. & Gottschalk, M. (1992). Studies on a murine model for evaluation of virulence of Streptococcus suis capsular type 2 isolates. FEMS Microbiol Lett 78, 111-116.
4. Brazeau, C., Vincelette, S., Gottschalk, M. & Martineau-Doizé, B. (1996). In vitro phagocytosis and survival of Streptococcus suis capsular type 2 inside murine macrophages. Microbiology 142, 1231-1237.
5. Caparon, M. G. & Scott, J. R. (1987). Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci. Proc Natl Acad Sci USA 84, 8677-86.
6. Caparon, M. G. & Scott, J. R. (1991). Genetic manipulation of pathogenic streptococci. Methods Enzymol 204, 556-586.
7. Charland, N., Kellens, J. T. C., Caya, F. & Gottschalk, M. (1995). Agglutination of Streptococcus suis by sialic acid-binding lectins. J Clin Microbiol 33, 2220-2221.
8. Charland, N., Kobisch, M., Martineau-Doizé, B., Jacques, M. & Gottschalk, M. (1996). Role of capsular sialic acid in virulence and resistance to phagocytosis of Streptococcus suis capsular type 2. FEMS Immunol Med Microbiol 14, 195-203.
9. Charland, N., Jacques, M., Lacouture, S. & Gottschalk, M. (1997). Characterization and protective activity of a monoclonal antibody against a capsular epitope shared by Streptococcus suis serotypes 1, 2 and 1/2. Microbiology 143, 3607-3614.
10. Clifton-Hadley, F. A. (1981). Studies of Streptococcus suis type 2 infection in pigs. PhD thesis, University of Cambridge.
11. Dale, J. B., Washburn, R. G., Marques, M. B. & Wessels, M. R. (1996). Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect Immun 64, 1495-1501.
12. Elliott, S. D. & Tai, J. (1978). The type-specific polysaccharides of Streptococcus suis. J Exp Med 148, 1699-1704.
13. Elliott, S. D., Clifton-Hadley, F. A. & Tai, J. (1980). Streptococcal infection in young pigs. V. An immunogenic polysaccharide from Streptococcus suis type 2 with particular reference to vaccination against streptococcal meningitis in pigs. J Hyg 85, 275-285.
14. Flannagan, S. E., Zitzow, L. A., Su, Y. A. & Clewell, D. B. (1994). Nucleotide sequence of the 18-kb conjugative transposon Tn916 from Enterococcus faecalis. Plasmid 32, 350-354.
15. Gawron-Burke, C. & Clewell, D. B. (1984). Regeneration of insertionally inactivated streptococcal DNA fragments after excision of transposon Tn916 in Escherichia coli: strategy for targeting and cloning of genes from Gram-positive bacteria. J Bacteriol 159, 214-221.
16. Gottschalk, M., Higgins, R., Jacques, M. & Dubreuil, D. (1992). Production and characterization of two Streptococcus suis capsular type 2 mutants. Vet Microbiol 30, 59-71.
17. Gottschalk, M., Lacouture, S. & Dubreuil, J. D. (1995). Characterization of Streptococcus suis capsular type 2 haemolysin. Microbiology 141, 189-195.
18. Gottschalk, M., Lebrun, A., Wisselink, H., Dubreuil, J. D., Smith, H. & Vecht, U. (1998). Production of virulence-related proteins by Canadian strains of Streptococcus suis capsular type 2. Can J Vet Res 62, 75-79.
19. Higgins, R. & Gottschalk, M. (1990). An update on Streptococcus suis identification. J Vet Diagn Invest 2, 249-252.
20. Higgins, R. & Gottschalk, M. (1996). Distribution of Streptococcus suis capsular types in 1995. Can Vet J 37, 242.
21. Higgins, R. & Gottschalk, M. (1998). Streptococcal diseases. In Diseases of Swine, chapter 38. Iowa: Iowa State University Press (in press).
22. Jacobs, A. A. C., Loeffen, P. L. W., Van Den Berg, A. J. G. & Storm, P. K. (1994). Identification, purification, and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis. Infect Immun 62, 1742-1748.
23. Jacques, M., Gottschalk, M., Foiry, B. & Higgins, R. (1990). Ultrastructural study of surface components of Streptococcus suis. J Bacteriol 172, 2833-2838.
24. Kasper, D. L. (1986). Bacterial capsule - old dogmas and new tricks. J Infect Dis 153, 407-415.
25. Katsumi, M., Saito, T., Kataoka, Y., Itoh, T., Kikuchi, N. & Hiramune, T. (1996). Comparative preparation methods of sialylated capsule antigen from Streptococcus suis type 2 with type specific antigenicity. J Vet Med Sci 58, 947-952.
26. Kim, K. S., Itabashi, H., Gemski, P., Sadoff, J., Warren, R. L. & Cross, A. S. (1992). The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat. J Clin Invest 90, 897-905.
27. Martin, T. R., Ruzinski, J. T., Rubens, C. E., Chi, E. Y. & Wilson, C. B. (1992). The effect of type-specific polysaccharide capsule on the clearance of group B streptococci from the lungs of infant and adult rats. J Infect Dis 165, 306-314.
28. Moxon, E. R. & Kroll, J. S. (1990). The role of bacterial polysaccharide capsules as virulence factors. Curr Top Microbiol Immunol 150, 65-85.
29. Nizet, V., Gibson, R. L., Chi, E. Y., Framson, P. E., Hulse, M. & Rubens, C. E. (1996). Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immun 64, 3818-3826.
30. Quessy, S., Dubreuil, J. D., Caya, M. & Higgins, R. (1995). Discrimination of virulent and avirulent Streptococcus suis capsular type 2 isolates from different geographical origins. Infect Immun 63, 1975-1979.
31. Reed, L. J. & Muench, H. (1938). A simple method of estimating the fifty percent endpoints. Am J Hyg 27, 493-497.
32. Rioux, S., Bégin, C., Dubreuil, J. D. & Jacques, M. (1997). Isolation and characterization of LPS mutants of Actinobacillus pleuropneumoniae serotype 1. Curr Microbiol 35, 139-144.
33. Rosenberg, M. (1984). Bacterial adherence to hydrocarbons: a useful technique for studying cell-surface hydrophobicity. FEMS Microbiol Lett 22, 289-295.
34. Rubens, C. E., Wessels, M. R., Heggen, L. M. & Kasper, D. L. (1987). Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci USA 84, 7208-7212.
35. Rubens, C. E., Heggen, L. M., Haft, R. F. & Wessels, M. R. (1993). Identification of cpsD, a gene essential for type III capsule expression in group B streptococci. Mol Microbiol 8, 843-855.
36. Salasia, S. I. O., Lämmler, C. & Herrmann, G. (1995). Properties of a Streptococcus suis isolate of serotype 2 and two capsular mutants. Vet Microbiol 45, 151-156.
37. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
38. Smith, H. E., Vecht, U., Wisselink, H. J., Stockhofe-Zurwieden, N., Biermann, Y. & Smits, M. A. (1996). Mutants of Streptococcus suis types 1 and 2 impaired in expression of muramidase-released protein and extracellular protein induce disease in newborn germfree pigs. Infect Immun 64, 4409-4412.
39. Tikkanen, K., Haataja, S. & Finne, J. (1996). The galactosyl-(α1-4)-galactose-binding adhesin of Streptococcus suis: occurrence in strains of different hemagglutination activities and induction of opsonic antibodies. Infect Immun 64, 3659-3665.
40. Trottier, S., Higgins, R., Brochu, G. & Gottschalk, M. (1991). A case of human endocarditis due to Streptococcus suis in North America. Rev Infect Dis 13, 1251-1252.
41. Vecht, U., Wisselink, H. J., Jellema, M. L. & Smith, H. E. (1991). Identification of two proteins associated with virulence of Streptococcus suis type 2. Infect Immun 59, 3156-3162.
42. Walsh, B., Williams, A. E. & Satsangi, J. (1992). Streptococcus suis type 2: pathogenesis and clinical disease. Rev Med Microbiol 3, 65-71.
43. Warren, L. (1963). Thiobarbituric acid assay of sialic acids. Methods Enzymol 6, 463-464.
44. Wessels, M. R., Moses, A. E., Goldberg, J. B. & DiCesare, T. J. (1991). Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci USA 88, 8317-8321.
45. Williams, A. E. (1990). Relationship between intracellular survival in macrophages and pathogenicity of Streptococcus suis type 2 isolates. Microb Pathog 8, 189-196.
46. Williams, A. E., Blakemore, W. F. & Alexander, T. J. (1988). A murine model of Streptococcus suis type 2 meningitis in the pig. Res Vet Sci 45, 394-399.